Overview

Study of Heparin Prophylaxis of Hereditary Angioedema Exacerbations

Status:
Completed
Trial end date:
1998-09-01
Target enrollment:
0
Participant gender:
All
Summary
OBJECTIVES: I. Determine the safety and efficacy of inhaled and subcutaneously administered heparin in the treatment of hereditary angioedema.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Iowa
Treatments:
Calcium heparin
Heparin
Criteria
PROTOCOL ENTRY CRITERIA:

--Disease Characteristics--

- Confirmed diagnosis of hereditary angioedema (HAE) based upon C4 antigenic level,
positive family history, and C1 inhibitor (C1INH) antigenic level (Type I HAE) or
functional level (Type II HAE)

- Functional C1 within normal levels if diagnosis of acquired C1INH is possible

- Negative family history will not exclude as long as patient meets all other criteria,
has normal C1 level, and has no evidence of acquired C1INH deficiency

- History of symptoms of HAE including episodic swelling, abdominal pain, and/or
respiratory difficulty

- Experiencing a minimum of 1-2 HAE episodes within 6 weeks

--Prior/Concurrent Therapy--

- Endocrine therapy: Anabolic steroids allowed as long as dose has not been changed in
at least 30 days

- Other: No concurrent and at least 1 week since prior aspirin, nonsteroidal
antiinflammatory agents, dipyridamole, Coumadin-like drugs, or any other medication
having an effect on coagulation or platelets

--Patient Characteristics--

- Hematopoietic: No clinically significant history of hematologic disease

- Hepatic: No clinically significant history of hepatic disease

- Renal: No clinically significant history of renal disease

- Cardiovascular: No clinically significant history of cardiac disease or hypertension

- Pulmonary: No clinically significant history of pulmonary disease

- Other: No contraindication to the use of inhaled or subcutaneous heparin No drug
allergy that would interfere with the study No clinically significant history of:
Malignancy Diabetes mellitus Neurologic disease Immunologic disease Bleeding disorder
Infirmity No history of drug abuse, alcoholism, psychosis, or other
psychological/psychiatric disorder